Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.cancer.org › types › breast-cancerTreatment of Triple-negative Breast Cancer | Treatment of TNBC

   www.cancer.org › types › breast-cancer

   • Zapisane w pamięci cache

   21 lip 2021 · How is triple-negative breast cancer (TNBC) treated? Learn more about the treatment options for stages 1 to 4 of triple-negative breast cancer here.

   • Immunotherapy

     By blocking PD-1, these drugs boost the immune response...

   • Hormone Therapy for Breast Cancer

     Hormone therapy after surgery for breast cancer. After...

   • Treating Breast Cancer During Pregnancy

     Surgery to remove the cancer in the breast and nearby lymph...

   • Chemotherapy for Breast Cancer

     This can be seen most often in women who have...

   • Treating Inflammatory Breast Cancer

     This can include chemo, targeted therapy, hormone therapy...

   • Targeted Drug Therapy

     Targeted therapy for HER2-positive breast cancer. In about...

   • Radiation for Breast Cancer

     Radiation therapy is treatment with high-energy rays (or...

   • Surgery for Breast Cancer

     Surgery for advanced breast cancer. Although surgery is very...

2. pmc.ncbi.nlm.nih.gov › articles › PMC8293164Cancer-Specific Outcomes in the Elderly with Triple-Negative...

   pmc.ncbi.nlm.nih.gov › articles › PMC8293164

   Triple-negative breast cancer is associated with worse stage-matched outcomes and a younger median age than other molecular subtypes of breast cancer. As a result, a growing body of evidence supports a subtype-specific, aggressive approach to multidisciplinary management.

3. cancerblog.mayoclinic.org › 2024/01/03 › understanding-triple-negative-breastUnderstanding triple-negative breast cancer and its treatment

   cancerblog.mayoclinic.org › 2024/01/03 › understanding-triple-negative-breast

   • Zapisane w pamięci cache

   3 sty 2024 · Triple-negative breast cancer, also called basal-like breast cancer, is a subtype that isn't affected by hormones or the HER2 gene. It grows rapidly, is more likely to spread beyond the breast before diagnosis and is more likely to recur than other breast cancers.

4. www.mybcteam.com › resources › treatment-for-triple-negative-breast-cancer-what-to5 Treatments for Triple-Negative Breast Cancer and Common Side...

   www.mybcteam.com › resources › treatment-for-triple-negative-breast-cancer-what-to

   • Zapisane w pamięci cache

   31 sty 2024 · Triple-negative breast cancer (TNBC) grows quickly and needs strong treatment. The term “triple-negative” means that the breast cancer cells test negative for estrogen receptors, progesterone receptors, and the protein HER2, which are common features in other types of breast cancer.

5. ascopubs.org › doi › 10Management of Older Women with Early-Stage Breast Cancer

   ascopubs.org › doi › 10

   14 maj 2015 · For older patients with triple-negative breast cancer and a life expectancy exceeding 5 years (the timeframe in which most of these tumors recur), the major systemic treatment consideration is chemotherapy.

6. www.mdanderson.org › cancerwise › triple-negative-breast-cancer-5-things-youTriple-negative breast cancer: 7 things you should know

   www.mdanderson.org › cancerwise › triple-negative-breast-cancer-5-things-you

   • Zapisane w pamięci cache

   21 maj 2024 · In most cases, chemotherapy is the most effective treatment option. Patients with stage I TNBC will typically get treated with chemotherapy, followed by surgery – either a lumpectomy or mastectomy; in some cases, they may need more chemotherapy after surgery. Some patients also get radiation therapy after surgery.

7. www.verywellhealth.com › triple-negative-breast-cancer-7254559What Is Triple-Negative Breast Cancer? - Verywell Health

   www.verywellhealth.com › triple-negative-breast-cancer-7254559

   • Zapisane w pamięci cache

   31 mar 2023 · Triple-negative breast cancer (TNBC) is a type of breast cancer that does not have hormone receptors. TNBC is diagnosed in 10% to 15% of all cases of breast cancer. Due to the lack of hormone receptors, there are limited treatment options.